O OftalmopediaAn open ophthalmology reference

Ocular rosacea

AI overview

Ocular rosacea is a type of rosacea that affects the eyes.

Key points
  • Ocular rosacea is a manifestation of rosacea affecting the eyes and eyelids.
    source quote
    Manifestation of rosacea affecting the eyes and eyelids
  • It may be caused by an overproliferation of Demodex mites D. folliculorum and D. brevis.
    source quote
    Ocular rosacea may be caused by an overproliferation of the Demodex mites D. folliculorum and D. brevis
  • Low-dose doxycycline improves symptoms through its anti-inflammatory effect rather than its antibiotic effect.
    source quote
    Low-dose doxycycline (50 mg pe day or less) improves the clinical symptoms of rosacea by its anti-inflammatory effect rather than by its antibiotic effect.
Symptoms
  • Signs and symptoms include redness, irritation or burning of the eyes.
    source quote
    redness, irritation or burning of the eyes
  • Affected individuals may feel that there is something, such as an eyelash, in the eye.
    source quote
    feel that there is something, such as an eyelash , in the eye
  • Affected individuals frequently have redness of the nose and cheeks as well.
    source quote
    frequently have redness of the nose and cheeks as well
  • Complications include corneal ulcer.
    source quote
    Complications include corneal ulcer
Treatment
  • Warm compresses, artificial tears, and washing the area around the eye with warm water can help relieve symptoms.
    source quote
    warm compresses , artificial tears and washing the area around the eye with warm water, including the eyelids, to help relieve symptoms
  • Oral antibiotics, typically doxycycline, may be prescribed.
    source quote
    oral antibiotics , typically doxycycline , may be prescribed
  • Doxycycline can be used at 100 mg once or twice a day for 2 to 3 months.
    source quote
    Doxycycline can be used in the treatment of ocular rosacea in dosages of 100 mg once or twice a day for a period of 2 to 3 months.
  • A dose of 50 mg once a day has good efficacy in less severe cases.
    source quote
    Other studies report a good efficacy of 50 mg once a day in less severe cases.
  • A 40 mg delayed-release formulation can be used for long-term therapy.
    source quote
    A formulation of 40 mg with a delayed release for long-term therapy can also be used.
  • Side effects of doxycycline include nausea, vomiting, photosensitivity, and headache.
    source quote
    Side effects of treating ocular rosacea with doxycycline include nausea, vomiting, photosensitivity and headache
  • Dietary restrictions of caffeine, spicy foods, and alcoholic beverages may reduce or eliminate symptoms.
    source quote
    dietary restrictions of caffeine , spicy foods, and alcoholic beverages may reduce or eliminate symptoms
  • Slow tapering or treatment with a lower dose over a longer period is recommended due to risk of recurrence.
    source quote
    many studies recommend either slow tapering or treatment with a lower dose over a longer period of time
Red flags
  • Corneal ulcer is a complication of ocular rosacea.
    source quote
    Complications include corneal ulcer
Prognosis

After discontinuation of doxycycline, recurrences may occur within three months.

AI-synthesized from the Wikipedia article “Ocular rosacea”. Not medical advice. Verify source →
Ocular rosacea
Person with ocular rosacea
SpecialtyOphthalmology

Ocular rosacea is a type of rosacea that affects the eyes.[1] Signs and symptoms generally consist of redness, irritation or burning of the eyes. Affected individuals may also feel that there is something, such as an eyelash, in the eye and frequently have redness of the nose and cheeks as well.[1] Complications include corneal ulcer.[2]

Those who have ocular rosacea may be treated with warm compresses, artificial tears and washing the area around the eye with warm water, including the eyelids, to help relieve symptoms. Additionally, oral antibiotics, typically doxycycline, may be prescribed.[3] Some people with ocular rosacea feel that dietary restrictions of caffeine, spicy foods, and alcoholic beverages may reduce or eliminate symptoms.

Ocular rosacea may be caused by an overproliferation of the Demodex mites D. folliculorum and D. brevis, both frequently referred to as "eyelash mites".

Doxycycline can be used in the treatment of ocular rosacea in dosages of 100 mg once or twice a day for a period of 2 to 3 months. Other studies report a good efficacy of 50 mg once a day in less severe cases. A formulation of 40 mg with a delayed release for long-term therapy can also be used. Side effects of treating ocular rosacea with doxycycline include nausea, vomiting, photosensitivity and headache, which may lead to premature discontinuation of treatment. After discontinuation of doxycycline, recurrences may occur within three months; therefore, many studies recommend either slow tapering or treatment with a lower dose over a longer period of time. Low-dose doxycycline (50 mg pe day or less) improves the clinical symptoms of rosacea by its anti-inflammatory effect rather than by its antibiotic effect.[4]

  1. 1 2 Wilkin, Jonathon; McGee, Jean S. (2023). "1. Introduction to clinical rosacea". In Cary, John Havens; Maibach, Howard I. (eds.). Rosacea. Switzerland: Springer. pp. 1–15. ISBN 978-3-030-52097-7. Archived from the original on 2023-07-22. Retrieved 2024-03-17.
  2. Dudee, Jitander (10 March 2023). "Ocular Rosacea: Background, Pathophysiology, Epidemiology". medicine.medscape.com. Medscape. Archived from the original on 22 July 2023. Retrieved 22 July 2023.
  3. Vieira, Ana Carolina; Mannis, Mark J. (December 2013). "Ocular rosacea: Common and commonly missed". Journal of the American Academy of Dermatology. 69 (6): S36–S41. doi:10.1016/j.jaad.2013.04.042. PMID 24229635.
  4. Avraham S, Khaslavsky S, Kashetsky N, Starkey SY, Zaslavsky K, Lam JM, Mukovozov I (February 2024). "Therapie der okulären Rosazea: Eine systematische Literatur-Übersicht: Treatment of ocular rosacea: a systematic review". J Dtsch Dermatol Ges. 22 (2): 167–176. doi:10.1111/ddg.15290_g. PMID 38361192.